Neola Medical AB (OSTO:NEOLA) ROE % Adjusted to Book Value: -12.65% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:NEOLA Neola Medical AB OSTO:NEOLA
28 GF Score
Price kr0.68
! 1 Warning Sign
View Full Analysis

What is Neola Medical AB ROE % Adjusted to Book Value?

Neola Medical AB OSTO:NEOLA -1.45% 28 ROE % Adjusted to Book Value is -12.65% as of Dec. 2025. GuruFocus rates OSTO:NEOLA with a GF Score™ of 28/100. The stock has 1 warning sign investors should review.

Neola Medical AB's ROE % for the quarter that ended in Dec. 2025 was -13.79%. Neola Medical AB's PB Ratio for the quarter that ended in Dec. 2025 was 1.09. Neola Medical AB's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 was -12.65%.

Neola Medical AB ROE % Adjusted to Book Value Related Terms

Neola Medical AB ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Neola Medical AB's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neola Medical AB ROE % Adjusted to Book Value Chart

Neola Medical AB Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE % Adjusted to Book Value
Get a 7-Day Free Trial -15.36 -17.25 -7.11 -6.63 -13.97

Neola Medical AB Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.29 -5.52 -6.23 -6.49 -12.65

OSTO:NEOLA vs ABT, SYK, MDT: ROE % Adjusted to Book Value Comparison

For the Medical Devices subindustry, Neola Medical AB's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Neola Medical AB ROE % Adjusted to Book Value vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Neola Medical AB's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Neola Medical AB's ROE % Adjusted to Book Value falls into.


OSTO:NEOLA
28GF Score
Neola Medical AB OSTO:NEOLA
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Neola Medical AB ROE % Adjusted to Book Value Calculation

Neola Medical AB's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-15.23% / 1.09
=-13.97%

Neola Medical AB's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-13.79% / 1.09
=-12.65%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of -12.65% mean?
Neola Medical AB (OSTO:NEOLA) has a ROE % Adjusted to Book Value of -12.65% as of Dec. 2025. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Neola Medical AB and its competitors.
Is Neola Medical AB's ROE % Adjusted to Book Value too high?
Neola Medical AB's current ROE % Adjusted to Book Value is -12.65%. Overall, Neola Medical AB has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Neola Medical AB's ROE % Adjusted to Book Value compare to ABT and SYK?
Neola Medical AB's ROE % Adjusted to Book Value of -12.65% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Medical Devices & Instruments company?
A good ROE % Adjusted to Book Value depends on the Medical Devices & Instruments industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Neola Medical AB and its competitors. Neola Medical AB's current ROE % Adjusted to Book Value is -12.65%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neola Medical AB stock overvalued right now?
Neola Medical AB (OSTO:NEOLA) has a current ROE % Adjusted to Book Value of -12.65%. The current ROE % Adjusted to Book Value is -12.65%. Neola Medical AB's overall GF Score™ is 28/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Neola Medical AB (OSTO:NEOLA), the current ROE % Adjusted to Book Value is -12.65% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Neola Medical AB Business Description

Address Scheelevagen 27, Ideon Science Park, Gateway 9th fl oor, Lund, SWE, 223 63
Neola Medical AB is revolutionizing neonatal intensive care with NEOLA, a medical device that can offer continuous lung monitoring and real-time alerts of life-threatening complications using a technology that measures lung volume changes and oxygen gas concentration. NEOLA has the potential to provide care, fewer days in intensive care, and healthier lives for preterm born infants. The company is building on a historic Swedish legacy of medical technology innovation and invaluable contributions to health care.
28GF Score

Get the complete analysis for OSTO:NEOLA

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.68
Price